Prime Medicine, Inc (PRME) insider trading
Every open-market stock purchase and sale by Prime Medicine, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: ARCH Venture Partners X LLC (10% owner), $10M, 14 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $2.96 on Jun 7, 2026.
Recent PRME insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 5, 2026 | Robert Nelsen (10% owner) | Bought (not open market) | — |
| Jun 5, 2026 | Jeffrey D Marrazzo (Director) | Bought (not open market) | — |
| Jun 5, 2026 | Thomas Cahill (Director) | Bought (not open market) | — |
| Jun 5, 2026 | Wendy Chung (Director) | Bought (not open market) | — |
| Jun 5, 2026 | David P Schenkein (Director) | Bought (not open market) | — |
| Jun 5, 2026 | Kaye I Foster-Cheek (Director) | Bought (not open market) | — |
| Jun 5, 2026 | Michael Aaron Kelly (Director) | Bought (not open market) | — |
| Apr 16, 2026 | Svetlana Ni Makhni (CFO) | Bought (not open market) | — |
| Feb 26, 2026 | Allan Reine (CEO) | Bought (not open market) | — |
| Feb 23, 2026 | Carman Alenson (Officer) | Bought (not open market) | — |
| Feb 23, 2026 | Ann L. Lee (CTO) | Bought (not open market) | — |
Who's trading PRME
- Jeffrey D Marrazzo, Director: other filings, last Jun 5, 2026
- Wendy Chung, Director: other filings, last Jun 5, 2026
- Kaye I Foster-Cheek, Director: other filings, last Jun 5, 2026
- Robert Nelsen, 10% owner: other filings, last Jun 5, 2026
- Michael Aaron Kelly, Director: other filings, last Jun 5, 2026
- David P Schenkein, Director: other filings, last Jun 5, 2026
- Thomas Cahill, Director: other filings, last Jun 5, 2026
- Svetlana Ni Makhni, CFO: other filings, last Apr 16, 2026
- Allan Reine, CEO: other filings, last Feb 26, 2026
- Ann L. Lee, CTO: other filings, last Feb 23, 2026
- Carman Alenson, Officer: other filings, last Feb 23, 2026
Get free alerts when an insider at Prime Medicine, Inc files a new trade →